Actionable insights — SK Hynix Bets AI Broke the Cycle

1. Treat an IPO/ADR as "probably overpriced" until a public quarter or two proves otherwise

1. Start from the author's default prior: "IPO stands for It's Probably Overpriced" — a listing is timed and priced by the seller, at the moment the story is most flattering.
2. Refine the prior for the specific deal: separate survival risk (a cash-burning startup) from price risk (a wildly profitable company where the only question is what you pay for peak earnings) — they demand different caution, but both argue against paying up on day one.
3. Default to the watchlist, not the buy: let the newly public line trade through a reporting period so the market — not the underwriter — sets the clearing price.

• Whether the raise is timed to the best-ever quarter; the split between survival risk and price risk; the discipline to wait for a post-listing print rather than chase the debut.

2. Ask how much of a peak-like margin survives when supply catches up

1. When a cyclical prints a record margin, don't extrapolate it — benchmark it against the industry's own history and against structurally higher-margin peers to see how abnormal it is.
2. Decompose the beat: is it price or volume? A margin driven almost entirely by price (ASP) with flat unit shipments is a shortage signal, and shortages mean-revert as capacity arrives.
3. Frame the real question as the buyer's question: not "does demand stay strong next quarter?" but "how much of this margin profile survives when new supply lands?"

• Price-vs-volume mix in the revenue beat; the margin vs the industry's prior cyclical peak (~60% here); the segment carrying it (HBM at 12% of DRAM revenue); the first quarter of decelerating ASPs.

3. Judge a capital raise by why it's raising — from strength or from need

1. Read the balance sheet behind the raise: a company with large net cash and a sold-out order book raising to expand is a very different signal from a cash-burning one raising to survive.
2. Watch the size drift: when a planned raise is deliberately upsized well beyond the original figure, that's management telling you internal demand forecasts have outrun the old playbook.
3. Note the structural constraints shaping the deal (ownership floors, share-issuance vs treasury stock) — they explain dilution that isn't about weakness.

• Net cash and order-book coverage at the raise; whether the target size was raised mid-process; ownership-rule constraints (SK Square's 20% floor) that force new shares over treasury sales.

4. Price a new listing against a pure comparable to expose the actual bet

1. Find the cleanest already-public comparable (same product, same cycle) and line up the multiples — forward P/E and a cash-flow multiple like EV/EBIT — side by side.
2. If the new name trades at parity with the comparable, the "premium for leadership" isn't being paid — so buying it is the same cyclical bet, just on the leader; only a widening premium later rewards the leadership.
3. Name the discount that's supposedly closing (governance, access) and ask whether closing it makes the stock cheap or merely accessible — access changes who can buy, not the price.

• The multiple gap (or lack of one) vs the comparable; whether a claimed discount closing makes it cheap or just liquid/index-eligible; whether the leader ever earns a premium.

5. Read the first weeks of trading as the most informative signal available

1. Treat the debut's pricing and early trading as a live referendum on the whole thesis — it's the first time the deepest pool of relevant buyers votes with real capital.
2. Define in advance what a "pass" vs "fail" looks like: a strong open that closes the valuation gap to the comparable validates the re-rating; a weak one says the buyer base still sees the old cyclical.
3. Use the debut to update, not to chase — a strong open is confirmation to keep watching, not license to pay any price.

• Pricing vs the ~$158 reference and the first weeks of trade; whether the gap to the comparable narrows; index-inclusion and institutional flow that support price separate from fundamentals.